Johns Hopkins University School of Medicine, Baltimore, MD, USA.
The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Eur Urol Focus. 2023 Jan;9(1):20-21. doi: 10.1016/j.euf.2022.10.008. Epub 2022 Nov 2.
The most common side effect of testosterone therapy (TT) is erythrocytosis. Patient-specific factors therefore should be considered when choosing an appropriate TT dosage and modality. Providers should decrease or discontinue therapy if the patient's hematocrit exceeds 54% until the hematocrit normalizes.
睾酮治疗（TT）最常见的副作用是红细胞增多症。因此，在选择合适的 TT 剂量和方式时，应考虑患者的具体情况。如果患者的红细胞压积超过 54%，应减少或停止治疗，直至红细胞压积恢复正常。
